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Background. President’s Emergency Plan for AIDS Relief (PEPFAR) funding changes have resulted in human
immunodeﬁciency virus (HIV) clinic closures. We evaluated linkage to care following a large-scale patient transfer
from a PEPFAR-funded, hospital-based HIV clinic to government-funded, community-based clinics in Durban.
Methods. All adults were transferred between March and June 2012. Subjects were surveyed 5–10 months post-
transfer to assess self-reported linkage to the target clinic. We validated self-reports by auditing records at 8 clinics.
Overall success of transfer was estimated using linkage to care data for both reached and unreached subjects, adjusted
for validation results.
Results. Of the 3913 transferred patients, 756 (19%) were assigned to validation clinics; 659 (87%) of those pa-
tients were reached. Among those reached, 468 (71%) had a validated clinic record visit. Of the 46 who self-reported
attending a different validation clinic than originally assigned, 39 (85%) had a validated visit. Of the 97 patients not
reached, 59 (61%) had a validated visit at their assigned clinic. Based on the validation rates for reached and un-
reached patients, the estimated success of transfer for the cohort overall was 82%.
Conclusions. Most patients reported successful transfer to a community-based clinic, though a quarter attended
a different clinic than assigned. Validation of attendance highlights that nearly 20% of patients may not have linked
to care and may have experienced a treatment interruption. Optimizing transfers of HIV care to community sites
requires collaboration with receiving clinics to ensure successful linkage to care.
Keywords. PEPFAR; transfer of HIV care; South Africa; linkage to care; community-based clinics.
South Africa, in partnership with the US President’s
Emergency Plan for AIDS Relief (PEPFAR), began to
roll out antiretroviral therapy (ART) in 2004 and now
has the largest ART program in the world, with over
2.4 million people on treatment [1, 2]. However, as
the program shifts toward “country ownership,” PEP-
FAR support to South Africa will decrease by almost
50% between 2012 and 2017, with a concomitant shift
in focus from providing direct medical care to offering
technical support [3–8]. The initial phase of PEPFAR
was implemented primarily through nongovernmen-
tal organizations, many of which were hospital-based
and doctor-managed facilities [9, 10]. Recent South
African guidelines have focused on nurse-initiated
ART [11]; with the decrease in direct medical care
funding provided by PEPFAR, patient care is now
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shifting to government-funded, nurse-managed primary
healthcare clinics in the community [12].
Limited data suggest similar clinical outcomes for those treat-
ed within nurse-managed primary healthcare clinics compared
to hospital-based programs [13–15]. However, these studies re-
ﬂect outcomes of selected, clinically stable patients referred to
community programs [16–18]. Further, in extant studies, nurses
at accepting clinics received additional training through a clin-
ical trial [13], the sickest patients were still cared for by doctors
[19], or a substantial fraction of patients refused the referral [14,
17]. Although studies from Malawi and Swaziland reveal less
lost to follow-up from primary healthcare centers compared
to hospital-based human immunodeﬁciency virus (HIV) pro-
grams, some also report higher mortality [14, 20–22].
The recent closure of a PEPFAR-funded, hospital-based HIV
clinic in Durban, South Africa, necessitated the rapid transfer of
patients to government-funded, community-based clinics. To
date, no study has evaluated a mandatory transfer of all patients,
regardless of clinical state, to primary healthcare centers. Given
that the highest rates of lost to follow-up generally occur in the
immediate transition between the last hospital-based visit and the
ﬁrst clinic visit [18], this clinic closure provided an opportunity
to perform real-time assessment of linkage to clinic-based care.
As funding for direct patient care declines, more hospital-based
and nongovernmental programs throughout sub-Saharan Africa
may close and transition patients to public sector community
clinics. We sought to assess initial linkage to transfer clinics fol-
lowing a large-scale transfer of HIV-infected patients from hos-
pital-based to primary healthcare clinics in South Africa.
METHODS
Study Site
McCord Hospital is a 142-bed state-aided, semiprivate general
hospital serving a predominantly urban population from the
greater Durban area. The Sinikithemba HIV clinic at McCord
began treating patients with ART in 1999 and became a
PEPFAR-funded site in 2004, rapidly expanding its clinical ser-
vices and becoming an integral part of the South African ART
scale-up. Sinikithemba served a predominantly African, Zulu-
speaking population and initiated over 10 000 patients on
ART. Because McCord Hospital was semiprivate, patients
paid a monthly, all-inclusive fee (180 ZAR [approximately 18
USD] based on the approximate exchange rate at the time of
transfer) for comprehensive outpatient care per South African
guidelines [11]. Patients were seen by both doctors and nurses
throughout the course of their ART initiation and long-term
care. In addition to being available daily for consultations,
doctors took on medically complex cases. The clinic had an
electronic medical record and a dedicated monitoring and eval-
uation team and was considered a Center of Excellence locally.
The HIV clinic was scheduled to lose PEPFAR funding and at
the end of 2011 created a transition plan to explore alternative
funding options. Due to the inability to secure alternative public
or private funding, the clinic had a short timeline to plan and
execute the transfer of all patients (stable and unstable) to the
public sector by the end of June 2012. Between July 2010 and
June 2011, 48% of patients enrolled at McCord were still in
care at the clinic, 29% changed providers with a formal transfer,
10% died, 9% were lost to follow-up, and 4% stopped treatment.
Sinikithemba Transfer Process
Patients were referred for transfer if they returned to the clinic for
clinical appointments, laboratories, or pharmacy reﬁlls between
March 12 and June 30, 2012, the “transfer period.” Patients
seen during this period underwent a group counseling session ex-
plaining the imminent clinic closure and transfer procedures. Pa-
tients were then individually evaluated by a clinician and a
counselor and transferred to one of 171 different clinics in the
Durban area (Fig. 1). The list of transfer clinics and the number
of patients each could absorb was compiled in collaboration with
districtmanagers from themunicipal and provincial Departments
of Health. Counselors identiﬁed target clinics for patients based
on their care needs and residential address, with the Department
of Health requesting that patients attend clinics within their des-
ignated geographic area. Patients taking ﬁrst-line ARTwere trans-
ferred to primary healthcare clinics; those taking second-line line
ART were transferred to community health clinics. Patients with
comorbidities requiring medications not on the South African Es-
sential Drug List [23] were referred to hospital-based clinics. Cli-
nicians completed a transfer form with clinical information for
patients to bring to their transfer clinic. In addition to demo-
graphic data, clinical data such as date of HIV diagnosis, baseline
and most recent CD4 count, current ART regimen, and current
contact details were entered into a database. Patients were issued 1
month of medication or a buffer supply of several months if their
transfer clinic appointment was delayed.
Most patients were assigned a transfer clinic at their ﬁrst visit
to Sinikithemba during the transfer period. However, acutely ill
or medically complex patients, those with suspected drug resis-
tance, those who recently initiated ART (in the 3 months prior),
and patients with recent ART regimen changes were ﬂagged
with a “red dot” sticker on their clinical folder. Red dot, or
“high-risk,” patients were retained in care and transferred at a
subsequent visit before clinic closure.
Study Population
The study population included all adults (≥18 years) on ART
who visited the clinic in the year prior to the transfer period.
Pre-ART patients were excluded from the formal transfer pro-
cess and also from this study. The study protocol was approved
by the McCord Hospital Research Ethics Committee (Durban,
South Africa) and the Partners Human Research Committee
(2012-P-001122/1, Boston, MA).
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Data Collection
Research assistants contacted patients by phone 5–10 months
after their last Sinikithemba visit to administer a brief question-
naire. Patients were asked about their HIV care, including
whether they attended their assigned transfer clinic, reasons
for delays or failures to link, whether they experienced treat-
ment interruption, and the date of their last transfer clinic
visit. During the phone interview, subjects were asked to give
oral consent to have anonymized transfer data used for research
purposes. Research assistants attempted to contact patients on 3
different days of the week and at different times. If a patient was
not reached after multiple attempts, they were considered un-
reached. Family members answering a subject’s phone who de-
scribed the subject as deceased were queried regarding the date
and cause of death. Responses were entered into a password-
protected electronic database.
The primary outcome of interest was linkage to care at the
referral clinic, deﬁned as a self-reported clinic visit within 90
days of transfer. This window reﬂects the period of time during
which patients would have needed to link to care to avoid a
treatment interruption. Secondary outcomes included: (1) a val-
idated transfer clinic visit, as documented by medical record re-
view and (2) death, as ascertained through family members
answering patients’ phones and cross-matching with the
South African death registry using national ID numbers [24].
Validation of Self-Report
We randomly selected a sample of clinics to validate patients’
self-reported ﬁrst transfer clinic visit. To facilitate access to clin-
ics by the research team, we selected the 80 clinics closest to the
hospital based on global positioning system (GPS) coordinates
and divided the clinics into deciles based on the cumulative
Fig. 1. Map showing the location of transfer clinics within 40 km of McCord Hospital, Durban, South Africa, and the relative number of people transferred
to that clinic (indicated by purple circle size). The inset includes points (red circles) for all transfer clinics and their geographic distribution. Clinics depicted
are those with street addresses for which GPS coordinates could be generated. Abbreviation: GPS, global positioning system.
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proportion of the cohort transferred there. One clinic was sam-
pled without replacement from each decile, with the goal of val-
idating at least 10% of patient visits.
Validation of self-reported visits to the sampled transfer clin-
ics was conducted by identifying a clinic record of patient visits
in ART registers and medical records. Patients were searched for
by name (English and Zulu), surname, date of birth, and South
African ID number. All patients assigned to a validation clinic,
regardless of whether they were reached for the phone question-
naire, were sought, as were patients who were assigned else-
where but self-reported attending one of the validation clinics.
If a patient was neither assigned to nor reported attending a val-
idation clinic, their records were not intentionally sought at the
validation clinic. Because not all clinics speciﬁcally marked the
records of McCord transfers, the number of patients found at
the validation clinics is a conservative ﬁgure. We estimated
the overall success of transfer for the entire cohort using the
rates of linkage to care for subjects reached and not reached
for the survey, adjusted for results of the validation visits:
¼ RðFAC þ EFSRÞ þ ð1 RÞUAC;
where R, percent of patients reached; FAC, percent of reached
patients found at their assigned clinic; E, percent among those
reached who were not found at assigned clinic and reported
going elsewhere; FSR, percent found among patients who self-
reported going to a nonassigned validation clinic; UAC, percent
of unreached patients found at their assigned clinic.
We calculated 95% conﬁdence intervals for the transfer rate es-
timate using a bootstrapping procedure with 1000 repetitions.
Univariate risk ratios with 95% conﬁdence intervals were used
to examine correlates of not being found at the validation clinic
to which the patient was assigned. To assess the independent im-
pact of red dot status on the likelihood of not being found at their
assigned transfer clinic, we used a Poisson regression model, con-
trolling for other factors potentially important to the outcome.
The model included red dot (high-risk) status, gender, age,
most recent CD4 count prior to transfer, distance of transfer clin-
ic from McCord, assignment to a community health clinic, and
whether the patient was reached for the survey. Associations were
examined at a P < .05 signiﬁcance level with 95% conﬁdence in-
tervals. We did not exclude any variables based on their P-values.
Statistical analyses were performed using Stata statistical software,
2008 (Stata Corporation, College Station, TX).
RESULTS
Cohort Characteristics
In the year prior to the transfer period, 4678 patients visited the
clinic (Fig. 2A) and were considered eligible for transfer. There
were 765 (16%) patients who did not visit during the March to
June 2012 transfer period: 482 (63%) changed service providers
prior to the transfer period, 179 (23%) were considered lost to
follow-up by the clinic for not having had a visit for 6 months or
more, and 104 (14%) died. Thus, 3913 (84%) eligible patients
had at least 1 visit during the transfer period and are considered
the transfer cohort. Of these, 3383 (86%) were reached for the
telephone survey, 500 (13%) were unreached, 3 (0.08%) refused
the survey, and 27 (0.7%) were known deaths. Fifty-nine percent
of the transfer cohort was female, with a mean age of 40 years
(standard deviation [SD] 9.5) and a most recent median CD4
count prior to transfer of 375/µL (interquartile range [IQR]
250–530/µL; Table 1). Two-thirds of patients (2537) were
transferred to a primary healthcare clinic. There were 254
(6%) high-risk (red dot) patients who were asked to return
for a subsequent visit during the transfer period. The baseline
characteristics of the reached and unreached groups did not dif-
fer substantially (Table 1).
Fig. 2. Schematic of patient transfers and clinic attendance. (A) Patients
eligible for transfer who had a visit and were reached after transfer.
(B) Self-reported outcomes for reached patients.
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Self-reported Linkage to Care
Of the 3383 patients reached for the survey, 3375 (99.8%) re-
ported attending a transfer clinic; 2410 (71%) said they went
to the clinic assigned to them byMcCord and 865 (26%) report-
ed going to a clinic other than the one assigned (Fig. 2B). The
most common reasons for attending alternative clinics were:
being told by the receiving clinic to go elsewhere (23%), stigma
concerns (16%), and inconvenient location (14%).
Validation of Self-reported Transfer Clinic Visits
The 10 validation clinics each had 27–275 patients assigned to
them for transfer. Two clinics were excluded from the validation
analysis. One clinic did not record identiﬁers such as name, date
of birth, or South African identiﬁcation number in their daily
visit log; they used only site-speciﬁc folder numbers, which
could not be linked to the study database variables. The other
clinic included names but no date of birth or South African
identiﬁcation number in their clinic register, therefore, identi-
ties could not be conﬁrmed.
Of the 756 transfer patients assigned to the 8 clinics used for
validation, the mean age was 40 years (SD 9.3), 61% were fe-
male, the median CD4 count prior to transfer was 370/µL
(IQR 262–530/µL), and 52 (7%) had red dot (high-risk) status.
These characteristics did not differ signiﬁcantly between the val-
idation cohort and the rest of the transfer cohort (all P > .05). 659
(87%) were reached for the survey. Among respondents, 468
(71%) were found at their assigned clinic (Fig. 3). An additional
46 people self-reported attending a validation clinic they were not
originally assigned to and, of these, 39 (85%) had a validated visit.
Of the 97 unreached patients, 59 (61%) were identiﬁed at their
assigned clinic. Based on the validation rates for reached patients
reporting attending assigned clinic, reached patients who self-
reported attending a different clinic and unreached patients, the
estimated success of transfer for the cohort overall was 82% (95%
conﬁdence interval [CI]: 79%–85%).
Correlates of Failure to be Found at Validation Clinic
For every 1 kilometer that the transfer clinic was from McCord,
patients were 7% more likely not to be found (adjusted relative
risk [aRR] 1.07, CI: 1.02–1.11; Table 2). Those assigned to a com-
munity health clinic, as opposed to a primary healthcare clinic or
hospital, were 70% more likely not to be found (aRR 1.70, CI:
1.20–2.42). Red dot or high-risk status was not associated with
failure to be found at the assigned validation clinic (aRR 1.03,
CI: 0.60–1.78).
DISCUSSION
We evaluated the rapid transfer of nearly 4000 patients from a
PEPFAR-funded, hospital-based HIV clinic to government-
funded community clinics. We reached 86% of patients with
clinic visits during the transfer period; of those, over 99%
self-reported visiting a clinic within 6 months of transfer. We
further evaluated these self-reported data through an audit of
records at 8 transfer clinics, which validated visits for 85% of
reached patients and 61% of unreached patients. Based on the
validation rates applied to the entire cohort, an overall estimated
82% were successfully transferred, suggesting that 18% of pa-
tients did not link to care after transfer to community-based
clinics. We did not ﬁnd an association between red dot (high
risk) patients and failure to successfully link to care.
Given the rapid and widespread nature of the transfer, that an
estimated 82% of nearly 4000 patients linked to care may be
considered a relative success and may reﬂect several strengths
within the process. This transfer was initiated from a well-
resourced clinic with: (1) close coordination between clinic
leadership and the Department of Health managers, (2) consid-
eration of patient preferences and speciﬁc clinical indications
for different levels of clinical care, and (3) highly motivated pa-
tients who received group and, if needed, individual counseling
related to ART adherence. Less well-resourced clinics may
not be able to achieve the success seen in this study. However,
promoting a smooth transition between doctor- and nurse-
managed clinics is especially important in light of qualitative
Table 1. Characteristics of Patients Who Visited McCord
Hospital during the Transfer Period, Comparing Those Reached
and Unreached by Phone Following Transfer
Total
N= 3913
Reached
N= 3383
Not Reached
N= 530
Female, N (%) 2324 (59) 2022 (60) 302 (57)
Age, Mean (SD) 40 (9.5) 40 (9.5) 40 (9.9)
Most recent CD4
count, Median/
µL (IQR)
375 (250–530) 376 (251–531) 366 (246–528)
Red dot, N (%)a 254 (6) 212 (6) 42 (8)
Transferred to
primary
healthcare
clinic, N (%)
2537 (65) 2225 (66) 312 (59)
Transferred to
community
health clinic,
N (%)
770 (20) 653 (19) 117 (22)
Transferred to
hospital-based
clinic, N (%)
524 (13) 446 (13) 78 (15)
Transferred to
private doctor,
N (%)
82 (2) 59 (2) 23 (4)
Abbreviations: ART, antiretroviral therapy; IQR, interquartile range; SD,
standard deviation.
a Red dot patients were those deemed “high-risk” for transfer: acutely ill or
medically complex patients, those in whom there were concerns about drug
resistance, recent ART initiates (prior 3 months), and patients with recent
ART regimen changes.
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evidence suggesting that transferring patients are more skeptical
of the care they receive in nurse-managed clinics [25].
Unlike prior studies, which have only assessed the transfer of
clinically stable patients [16–18], all patients at the Sinikithemba
clinic were transferred, regardless of their desire to transfer or
their clinical condition. Red dot patients, who might have
been excluded from prior studies due to suspected drug resis-
tance, recent ART initiation, or signiﬁcant comorbidities, had
similar validated linkage rates. This suggests that patients previ-
ously seen as high-risk for transfer may be transferred safely.
Notably, patients whose transfer clinic was further from
McCord were less likely to be found, supporting the idea that
some patients purposefully travel a great distance to avoid
being recognized at a local clinic [26]. Convenience or transport
concerns might motivate patients to elect a closer clinic; howev-
er, concerns about stigma might impel them to choose a more
distant clinic. The latter concern is evidenced by patients, all of
whom were assigned to geographically close clinics, reporting
“inconvenient location” as a reason for attending a nonassigned
clinic. These data suggest that patient transfer preferences
should be considered when choosing a transfer location.
Fig. 3. Number and proportion of patients reached and unreached by phone following transfer, including only the 756 patients assigned to the validation
clinics. Patients are further delineated by whether they were found in the clinic record at the validation clinic, were not found in the record, or reported going
elsewhere.
Table 2. Correlates of Not Being Found at Assigned Transfer
Clinics Visited for Validation
Factors
Unadjusted relative
risk (95% CI)
Adjusted relative
risk (95% CI)
Female 1.03 (0.78–1.34) 1.02 (0.78–1.33)
Age group (under 30) 1.30 (0.89–1.89) 1.27 (0.87–1.86)
Most recent CD4
count (per
quartile)
1.05 (0.94–1.18) 1.06 (0.94–1.19)
Distance from
McCord to transfer
clinica
1.08 (1.04–1.12) 1.07 (1.02–1.11)
Red dot status 0.97 (0.57–1.64) 1.03 (0.60–1.78)
Assigned to
community health
clinicb
1.92 (1.37–2.70) 1.70 (1.20–2.42)
Reached for survey 1.35 (0.95–1.91) 1.29 (0.91–1.84)
Relative risk: risk for failure to be found at validation clinic.
Abbreviations: aRR, adjusted relative risk for failure to be found at validation
clinic, adjusted for all characteristics shown; ART, antiretroviral therapy; CI,
confidence interval.
a For every 1 km that the transfer clinic was from McCord, patients were 10%
less likely to be found.
b Patients on second-line ART were assigned to community health clinics.
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A quarter of transferred patients reported attending a differ-
ent clinic than assigned. Their reasons are consistent with other
studies in sub-Saharan Africa, which ﬁnd that lack of transport
to clinic [27–29] and stigma [30–33]greatly alter a patient’s abil-
ity to engage in care. Given that nearly one-quarter of those at-
tending a different clinic from the one assigned reported being
turned away from their assigned clinic, efforts to optimize trans-
fers to community-based sites will require close collaboration
with receiving clinics to ensure successful linkage to care. Coor-
dinating with the Department of Health to ensure a compre-
hensive list of available sites by geographic area may prevent
confusion about the appropriateness of a chosen clinic.
As PEPFAR funding decreases in South Africa, additional
large, centralized HIV clinics may be closed and care shifted
to South Africa’s health system. Despite the notable success of
the Sinikithemba transfer process, we estimate 18% of trans-
ferred patients may not have linked to care. This represents a
substantial proportion of the cohort that may have experienced
treatment interruption. Those who were lost from care have a
heightened risk of clinical complications and viral rebound, po-
tentially increasing their risk of morbidity and onward HIV
transmission. Although South African ownership of direct
medical care is an important goal, rapid shifts that result in sig-
niﬁcant interruptions in care jeopardize the important health
gains made [6]. In order to ensure that the signiﬁcant progress
made in HIV treatment is maintained, the South African gov-
ernment and PEPFAR should consider the existing medical in-
frastructure and the readiness of public clinics to accept a rapid
inﬂux of patients [5,9]. Standardized transfer procedures and
documentation, including clear expectations about geographic
limitations for patient transfers, will facilitate this process. Fur-
thermore, consistent use of a single patient identiﬁer would
allow for more effective tracking of patients between sites and
would enable the health system to identify patients who have
been lost to follow-up [34]. The current study speaks only to
an initial transfer clinic visit; the outcomes of transitions in
care should be formally monitored to assess not only linkage
to care but also retention in care, ART adherence, and ongoing
virologic suppression. This type of long-term data gathering is
imperative to better inform future clinic closures, ensure that
patient care is not compromised, and maximize the continued
beneﬁt of PEPFAR aid, even as funding diminishes.
There are several possible explanations for the differential
validation rates between the reached and unreached cohorts. Pa-
tients were tried 3 times over several weeks on different days and
at different times in order to maximize the likelihood of a re-
sponse. This is consistent with studies that show that up to
83% of patients lost to follow-up were unreachable by phone
due to incorrect or incomplete contact information [35–37]. It
is also possible that some unreached participants intentionally
did not answer or return calls from research assistants because
they did not want to admit that they had failed to attend their
transfer clinic. By collecting self-reported clinic attendance and
validating a portion of the self-reports, we were able to make a
more nuanced estimation of the overall linkage to care rate for
the cohort.
This study should be viewed in the context of several limita-
tions. Those patients who attended the clinic during the transfer
period may represent the most motivated. We do not know the
outcomes for those who were eligible for transfer but did not
attend during the transfer period; therefore, we may have over-
estimated the success of the transfer process. About 14% of
transferred patients were not reached by phone. Though some
were found at their assigned clinic, others may have successfully
transferred to another clinic without our knowledge. The pri-
mary outcome relied on patients’ self-reports of clinic atten-
dance and may thus be subject to social desirability bias. The
validation process was used to correct for such bias. Linkage
to the transfer clinic was successfully validated for the majority
of patients from the transfer cohort. However, due to differences
in record-keeping methods, there was variability in how patients
were identiﬁed in records, and we may not have found all pa-
tients with transfer clinic visits. Further, we had to exclude 2
of the validation sites because records were inconsistent and in-
complete. One of these clinics had 275 patients assigned to it;
this would have increased our validation group by nearly 30%
and may have added to the robustness of our ﬁndings. We sam-
pled from the 80 clinics closest to McCord, which may have bi-
ased the results toward a higher rate of linkage to care. Finally,
because Sinikithemba patients paid a monthly fee for care, they
may represent a more motivated and ﬁnancially stable cohort
than is typically found in public, hospital-based clinics where
care is free of charge. These patients’ ﬁnancial investment in
their HIV treatment may have made them more likely to link
to a transfer clinic.
This study demonstrates that when PEPFAR support is with-
drawn from a high-volume clinic, a substantial proportion of
patients can be successfully transferred to community clinics.
However, even under circumstances where the transfer process
was carefully coordinated, nearly 20% of patients were not
found to have had a ﬁrst visit at a sample of validation clinics.
To truly assess the impact of a large-scale transfer of this nature,
outcomes beyond the ﬁrst transfer clinic visit, such as long-term
retention in care, adherence to treatment, and virologic sup-
pression, must be evaluated. During this time of transition to
South African government-supported HIV care, efforts are ur-
gently needed to strengthen monitoring systems and methods
for retaining patients in care to ensure that the remarkable
gains supported by PEPFAR are not lost.
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